APL2

· Apellis Pharmaceuticals, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for APL2, covering 2025-10-09 to 2025-10-09. Get the full timeline:

Most recent: Clinical Trial Update: A Sequential Phase 2/3 Study of APL2 in Patients With Focal Segmental Glomerulosclerosis [Phase 2, Phase 3]